Search results
FDA Issues Warning Letter To Toltrazuril Shop Over Sale Of EPM Medication
Paulick Report· 15 hours agoThe warning letter is dated May 16 of this year and gives CEO Yvette Pittman 15 business days to notify the FDA about steps the company has taken to bring itself back into ...
Supreme Court decision guide: A breakdown of major cases and rulings expected in June and early July
Yahoo News· 12 minutes agoAbortion pill access Cases consolidated into one: FDA v. Alliance for Hippocratic Medicine; Danco...
Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone
WFMZ Eastern Pennsylvania and Western New Jersey· 17 hours agoSupreme Court Upholds , FDA Regulation on Popular , Abortion Drug Mifepristone. On June 13, the...
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
AOL· 1 day agoA U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic stress disorder (PTSD) that are often used in veteran care. On June 4, the ...
Seasoning recall update as FDA sets most severe level
Newsweek· 1 day agoThe U.S. Food and Drug Administration (FDA) has issued its most severe type of food recall after...
FDA grants orphan drug status to tafenoquine for babesiosis By Investing.com
Investing.com· 3 days agoThe U.S. Food and Drug Administration (FDA) has awarded orphan drug designation to 60 Degrees...
FDA considers ban of hair relaxers used by Black women and linked to serious health issues, report...
Staten Island Advance· 21 hours agoRecent studies supporting a long-suspected link between cancer and hair relaxers used by Black women...
The Ignored Aesthetic Standing Argument In FDA v. Alliance for Hippocratic Medicine
Reason.com· 10 hours agoIn FDA v. Alliance for Hippocratic Medicine, the Court rejected three theories of standing: (1) expected conscience objections, (2) expected monetary harms, and (3) diversion ...
FDA Expands Repotrectinib Label
Medscape· 1 day agoThe new accelerated approval for the TKI was based on the overall response rate in 48 patients.
Supreme Court Rules In Favor of the FDA in Mifepristone Case
The American Conservative· 18 hours agoIn its first ruling on abortion-related matters since the 2022 overturning of Roe v. Wade, the...